Published in Clin Infect Dis on February 01, 2006
Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev (2007) 15.66
Cavitary pulmonary disease. Clin Microbiol Rev (2008) 2.31
Clinical and laboratory update on blastomycosis. Clin Microbiol Rev (2010) 2.01
Geographic distribution of endemic fungal infections among older persons, United States. Emerg Infect Dis (2011) 1.94
Epidemiology of cryptococcal meningitis in the US: 1997-2009. PLoS One (2013) 1.69
Adaptive immunity to fungi. Annu Rev Immunol (2012) 1.41
Clinical use of anti-TNF therapy and increased risk of infections. Drug Healthc Patient Saf (2013) 1.31
Definition of the extracellular proteome of pathogenic-phase Histoplasma capsulatum. J Proteome Res (2011) 1.22
Parallels in fungal pathogenesis on plant and animal hosts. Eukaryot Cell (2006) 1.20
Fungal infections in intensive care unit: challenges in diagnosis and management. Ann Med Health Sci Res (2013) 1.09
Duodenal histoplasmosis presenting with upper gastrointestinal bleeding in an AIDS patient. Case Rep Gastrointest Med (2012) 0.99
Galleria mellonella as a model host to study Paracoccidioides lutzii and Histoplasma capsulatum. Virulence (2013) 0.97
Antibody therapy for histoplasmosis. Front Microbiol (2012) 0.96
Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis. Arthritis Rheum (2013) 0.96
Production and evaluation of reagents for detection of Histoplasma capsulatum antigenuria by enzyme immunoassay. Clin Vaccine Immunol (2007) 0.93
A monoclonal antibody to Histoplasma capsulatum alters the intracellular fate of the fungus in murine macrophages. Eukaryot Cell (2008) 0.93
Two-component signal transduction proteins as potential drug targets in medically important fungi. Infect Immun (2008) 0.92
Reverse genetics through random mutagenesis in Histoplasma capsulatum. BMC Microbiol (2009) 0.92
Vaccines for invasive fungal infections. F1000 Med Rep (2011) 0.92
Conidia but not yeast cells of the fungal pathogen Histoplasma capsulatum trigger a type I interferon innate immune response in murine macrophages. Infect Immun (2010) 0.88
The Use of Endobronchial Ultrasound in the Diagnosis of Subacute Pulmonary Histoplasmosis. Diagn Ther Endosc (2015) 0.86
Comparative transcriptomics of infectious spores from the fungal pathogen Histoplasma capsulatum reveals a core set of transcripts that specify infectious and pathogenic states. Eukaryot Cell (2013) 0.85
Blastomyces dermatitidis yeast cells inhibit nitric oxide production by alveolar macrophage inducible nitric oxide synthase. Infect Immun (2011) 0.83
The unappreciated intracellular lifestyle of Blastomyces dermatitidis. J Immunol (2015) 0.83
Incidence and trends of blastomycosis-associated hospitalizations in the United States. PLoS One (2014) 0.82
Antifungal therapeutics for dimorphic fungal pathogens. Virulence (2016) 0.81
Experimental annotation of the human pathogen Histoplasma capsulatum transcribed regions using high-resolution tiling arrays. BMC Microbiol (2011) 0.81
Identification of an aminothiazole with antifungal activity against intracellular Histoplasma capsulatum. Antimicrob Agents Chemother (2013) 0.80
Blastomycosis mortality rates, United States, 1990-2010. Emerg Infect Dis (2014) 0.79
Quantitative Microplate-Based Growth Assay for Determination of Antifungal Susceptibility of Histoplasma capsulatum Yeasts. J Clin Microbiol (2015) 0.79
MyD88-dependent signaling drives host survival and early cytokine production during Histoplasma capsulatum infection. Infect Immun (2015) 0.78
Impact of methamphetamine on infection and immunity. Front Neurosci (2015) 0.78
Diagnostic value of culture and serological tests in the diagnosis of histoplasmosis in HIV and non-HIV Colombian patients. Am J Trop Med Hyg (2013) 0.78
Histoplasma capsulatum, lung infection and immunity. Future Microbiol (2015) 0.77
Histoplasmosis in Idaho and Montana, USA, 2012-2013. Emerg Infect Dis (2015) 0.77
Fungal vaccines and immunotherapeutics. Cold Spring Harb Perspect Med (2014) 0.77
Genome-Wide Reprogramming of Transcript Architecture by Temperature Specifies the Developmental States of the Human Pathogen Histoplasma. PLoS Genet (2015) 0.76
Enhancing pathogen identification in patients with meningitis and a negative Gram stain using the BioFire FilmArray(®) Meningitis/Encephalitis panel. Ann Clin Microbiol Antimicrob (2016) 0.76
Pediatric Coccidioidomycosis Patients: Perceptions, Quality of Life and Psychosocial Factors. Healthcare (Basel) (2015) 0.75
Coccidioidomycosis: Experience From a Children's Hospital in an Area of Endemicity. J Pediatric Infect Dis Soc (2014) 0.75
Blastomyces Antigen Detection for Diagnosis and Management of Blastomycosis. J Clin Microbiol (2015) 0.75
CD103+ Conventional Dendritic Cells Are Critical for TLR7/9-Dependent Host Defense against Histoplasma capsulatum, an Endemic Fungal Pathogen of Humans. PLoS Pathog (2016) 0.75
Design, synthesis, and biological evaluation of aminothiazole derivatives against the fungal pathogens Histoplasma capsulatum and Cryptococcus neoformans. Bioorg Med Chem (2014) 0.75
Enhanced virulence of Histoplasma capsulatum through transfer and surface incorporation of glycans from Cryptococcus neoformans during co-infection. Sci Rep (2016) 0.75
65-year-old man with persistent fever. Mayo Clin Proc (2009) 0.75
Histoplasmosis-Associated Hospitalizations in the United States, 2001-2012. Open Forum Infect Dis (2016) 0.75
Intracranial blastomycotic abscess mimicking malignant brain neoplasm: Successful treatment with voriconazole and surgery. Surg Neurol Int (2015) 0.75
Inverse Correlation between IL-10 and HIF-1α in Macrophages Infected with Histoplasma capsulatum. J Immunol (2016) 0.75
Molecular identification of fungi found on decomposed human bodies in forensic autopsy cases. Int J Legal Med (2014) 0.75
A necrotic tonsillar lesion: An unusual presentation of disseminated histoplasmosis. Respir Med Case Rep (2017) 0.75
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis (2009) 18.19
Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis (2005) 13.97
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med (2007) 10.40
Pediatric do-not-attempt-resuscitation orders and public schools: a national assessment of policies and laws. Am J Bioeth (2005) 8.45
Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med (2007) 5.88
Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis (2012) 5.66
Guidelines for treatment of candidiasis. Clin Infect Dis (2003) 5.55
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis (2010) 5.53
The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis (2005) 5.25
Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis (2010) 4.98
Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis (2005) 4.31
Children with complex chronic conditions in inpatient hospital settings in the United States. Pediatrics (2010) 3.84
Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis (2009) 3.77
Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis (2003) 3.70
Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics (2002) 3.22
SUPPORT and the Ethics of Study Implementation: Lessons for Comparative Effectiveness Research from the Trial of Oxygen Therapy for Premature Babies. Hastings Cent Rep (2014) 3.15
Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. Clin Infect Dis (2004) 3.10
Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis (2004) 2.98
Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis (2004) 2.89
Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med (2005) 2.79
Neurologic complications in children hospitalized with influenza: characteristics, incidence, and risk factors. J Pediatr (2007) 2.75
Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin. J Infect Dis (2003) 2.73
Infections caused by Scedosporium spp. Clin Microbiol Rev (2008) 2.69
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis (2008) 2.55
Hospital utilization and characteristics of patients experiencing recurrent readmissions within children's hospitals. JAMA (2011) 2.45
Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques. Pediatrics (2003) 2.38
Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007. Pediatrics (2009) 2.35
Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children's hospitals in the United States. Clin Infect Dis (2009) 2.31
Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia. Antimicrob Agents Chemother (2002) 2.30
Zygomycosis in children: a systematic review and analysis of reported cases. Pediatr Infect Dis J (2007) 2.25
Combination antifungal therapy for invasive aspergillosis: a randomized trial. Ann Intern Med (2015) 2.18
Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis (2010) 2.15
Pathogenesis of mucormycosis. Clin Infect Dis (2012) 2.14
Caspofungin therapy of neonates with invasive candidiasis. Pediatr Infect Dis J (2004) 2.08
Human rhinoviruses. Clin Microbiol Rev (2013) 2.05
Effects of corticosteroid on Henoch-Schönlein purpura: a systematic review. Pediatrics (2007) 2.05
Antibiotic exposure and IBD development among children: a population-based cohort study. Pediatrics (2012) 2.04
Placement stability and mental health costs for children in foster care. Pediatrics (2004) 2.01
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation. Blood (2010) 1.97
Treatment with oseltamivir in children hospitalized with community-acquired, laboratory-confirmed influenza: review of five seasons and evaluation of an electronic reminder. J Hosp Med (2009) 1.95
The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies. Clin Infect Dis (2014) 1.94
Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae. J Infect Dis (2008) 1.88
Risk factors for fluconazole-resistant Candida glabrata bloodstream infections. Arch Intern Med (2009) 1.86
Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics (2010) 1.86
Empirical therapy for neonatal candidemia in very low birth weight infants. Pediatrics (2003) 1.86
Socioeconomic disparities in the use and success of fertility treatments: analysis of data from a prospective cohort in the United States. Fertil Steril (2011) 1.85
Surveillance cultures for detection of methicillin-resistant Staphylococcus aureus: diagnostic yield of anatomic sites and comparison of provider- and patient-collected samples. Infect Control Hosp Epidemiol (2009) 1.85
Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection. Arch Intern Med (2005) 1.82
Beyond cat scratch disease: widening spectrum of Bartonella henselae infection. Pediatrics (2008) 1.80
Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans. Antimicrob Agents Chemother (2002) 1.79
The OHRP and SUPPORT. N Engl J Med (2013) 1.78
Clostridium difficile Infection in children. JAMA Pediatr (2013) 1.76
Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Clin Infect Dis (2004) 1.74
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med (2013) 1.74
Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits. Antimicrob Agents Chemother (2002) 1.72
Histoplasmosis-associated cross-reactivity in the BioRad Platelia Aspergillus enzyme immunoassay. Clin Vaccine Immunol (2007) 1.70
Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network. J Clin Microbiol (2009) 1.68
Emerging and less common fungal pathogens. Infect Dis Clin North Am (2002) 1.68
Newer systemic antifungal agents : pharmacokinetics, safety and efficacy. Drugs (2004) 1.67
Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection. JAMA (2005) 1.67
A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia. Pediatr Infect Dis J (2010) 1.66
A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis. Clin Infect Dis (2004) 1.64
Improving the care of children with advanced cancer by using an electronic patient-reported feedback intervention: results from the PediQUEST randomized controlled trial. J Clin Oncol (2014) 1.63
The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates. J Infect Dis (2008) 1.62
Emergence of disseminated candidiasis caused by Candida krusei during treatment with caspofungin: case report and review of literature. Med Mycol (2005) 1.61
Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate. Antimicrob Agents Chemother (2002) 1.61
Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients. Antimicrob Agents Chemother (2005) 1.59
Oseltamivir shortens hospital stays of critically ill children hospitalized with seasonal influenza: a retrospective cohort study. Pediatr Infect Dis J (2011) 1.59
Variation in receipt of opioids by pediatric oncology patients who died in children's hospitals. Pediatr Blood Cancer (2009) 1.56
A novel application of 1H magnetic resonance spectroscopy: non-invasive identification of spermatogenesis in men with non-obstructive azoospermia. Hum Reprod (2010) 1.56
Parental decision-making preferences in the pediatric intensive care unit. Crit Care Med (2012) 1.55
Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections. Antimicrob Agents Chemother (2006) 1.55
Incidence, complications, and risk factors for prolonged stay in children hospitalized with community-acquired influenza. Pediatrics (2007) 1.54
Identifying targets for antimicrobial stewardship in children's hospitals. Infect Control Hosp Epidemiol (2013) 1.54
Racial differences in vasectomy utilization in the United States: data from the national survey of family growth. Urology (2009) 1.53
Pediatric hospital discharge interventions to reduce subsequent utilization: a systematic review. J Hosp Med (2013) 1.50
Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases. Pediatrics (2008) 1.49
Echinocandins--an advance in the primary treatment of invasive candidiasis. N Engl J Med (2002) 1.49
Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies. Leuk Lymphoma (2012) 1.47
Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study. Clin Infect Dis (2002) 1.47
Fecundity and sex ratio of offspring in an infertile cohort. Fertil Steril (2011) 1.47
Wet heat exposure: a potentially reversible cause of low semen quality in infertile men. Int Braz J Urol (2007) 1.47
Men who seek infertility care may not represent the general U.S. population: data from the National Survey of Family Growth. Urology (2011) 1.47
Issues related to the design and interpretation of clinical trials of salvage therapy for invasive mold infection. Clin Infect Dis (2006) 1.46
In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection. Antimicrob Agents Chemother (2004) 1.44
Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria. Diagn Microbiol Infect Dis (2011) 1.42
Patterns of medication exposures in hospitalized pediatric patients with acute renal failure requiring intermittent or continuous hemodialysis. Pediatr Crit Care Med (2013) 1.42
Antifungal chemotherapy: advances and perspectives. Swiss Med Wkly (2002) 1.42
Epidemiology of Polypharmacy and Potential Drug-Drug Interactions Among Pediatric Patients in ICUs of U.S. Children's Hospitals. Pediatr Crit Care Med (2016) 1.42
Combination therapy for mucormycosis: why, what, and how? Clin Infect Dis (2012) 1.41
Factors associated with pediatric critical care attending follow-up with families after the death of a patient: a national survey with an experimental design. Pediatr Crit Care Med (2011) 1.41
Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy. J Infect Dis (2006) 1.41